Becton, Dickinson and Co. | BDX - Ordinary Share Capital


Becton, Dickinson and Co. reported $370.59M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Agilent USD 281.97M 252K Jun/2026
Align Technology USD 71.62M 1000 Jun/2026
AngioDynamics USD 41.57M 127K Sep/2025
Baxter International USD 517M 549K Jun/2026
Becton, Dickinson and Co. USD 370.59M 95.05M Jun/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Boston Scientific USD 1.48B 2.66M Dec/2025
Cooper Companies USD 190.1M 5.01M Jun/2026
Danaher USD 702.9M 4.8M Jun/2026
Dentsply International USD 199.2M 1.1M Jun/2026
Dexcom USD 377.4M 8.5M Jun/2026
Edwards Lifesciences USD 577M 3.7M Mar/2026
Globus Medical USD 135.67M 611K Mar/2026
Insulet USD 69.35M 87K Jun/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
Intuitive Surgical USD 354.16M 1.01M Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Medtronic USD 1.28B 130K Jun/2026
Solventum Corp USD 170.11M 3.42M Jun/2026
Stryker USD 383.4M 416K Jun/2026
Tandem Diabetes Care USD 69.54M 1.04M Jun/2026
Teleflex USD 44.26M 70K Mar/2026
Terumo JPY 1.48B 19K Jun/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
Zimmer Biomet Holdings USD 193.4M 2.1M Jun/2026